Belgian reimbursement system for medical devices and IVD tests

This online on-demand seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in Belgium. Additional modules cover reimbursement of IVD tests and medical aids

Provided in the form of a presentation in Acrobat PDF

Request a quote

Belgium is one of the rare countries in Europe that has a fee-for-service payment mechanism for hospital care. In addition to the INAMI fees for drugs, as well as physician and other services, hospitals also receive a budget for ward stay/other hospital activities.

The main goal of the market access activities for the majority of the procedures is the creation of the procedure code in the INAMI Nomenclature and inclusion into the List of reimbursable implantable and invasive devices. The role of the DRG is minor; APR-DRG is used only for a small number of low-variable procedures.

In addition, one Coverage with Evidence Development scheme exists, the goal of which is to provide temporary reimbursement in a limited number of centres to generate additional evidence to inform further decision-making about permanent reimbursement for implantable and invasive medical devices in Belgium.

It is essential for medical device and IVD companies to understand the pathways to the ultimate goal of reimbursement in Belgium. We offer a seminar on critical elements of the hospital reimbursement system for medical devices that can guide your decision-making in this complex country.

What topics are reviewed?

Key stakeholders and their role in reimbursement processes

Key stakeholders are reviewed, including payers (sickness funds), policy-makers (National Sickness and Invalidity Insurance Institution, INAMI/RIZIV)), decision influencers (Health Care Knowledge Centre, KCE)

Money flow, payment system, INAMI nomenclature and List of devices

Money flow and distribution of funds, INAMI nomenclature and List of devices, hospital conventions, role of DRG

Role of HTA, pathways to establish reimbursement

Role of Health Technology Assessment, different pathways to establish reimbursement, coverage with evidence development, pricing for medical devices

Additional modules

Reimbursement system for in-vitro diagnostic tests

A separate comprehensive overview of the reimbursement system for IVD tests in Belgium

Reimbursement system for medical aids

A separate comprehensive overview of the reimbursement system for medical aids in Belgium

What topics are not covered?

Some topics are not specifically covered in this seminar: reimbursement of health apps, funding of capital equipment

The introductory presentation also does not include details of reimbursement application processes (for example application form, requirements, details of the process for the inclusion of a new service in the INAMI/RIZIV nomenclature or adding a new device on the List)

Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy

How is the seminar delivered?

Presentation in Acrobat PDF

At the moment, you can only access the educational material as the full presentation of the seminar in Acrobat PDF

Updates of the seminar

April 2020: Update of the overview of the Belgian IVD reimbursement system (new decision influencers introduced to the summary of stakeholders, new process of applying for reimbursement of new IVD tests, evidence requirements for the new process of applying for reimbursement for new IVD tests)

Request a quote

Click the button below to request a quote for the seminar

Do you have any remaining questions?

Check if they are answered at the main page or contact us
Check the main page

50% Complete

Two Step

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.